Arch Biopartners Inc.
ARCH.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 63.26% | -25.22% | 24.12% | -47.98% | -416.14% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -174.79% | 3,020.13% | -96.85% | 171.34% | 121.23% |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | -87.26% | 45.45% | -66.45% | 5.53% | 37.02% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 1,311.11% | -88.54% | 528.00% | 8.23% | -96.92% |
| Total Debt Repaid | -- | -- | -- | 75.44% | 97.33% |
| Issuance of Common Stock | 4.54% | -43.93% | 342.03% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 200.00% | -- | -- | -- |
| Cash from Financing | 116.98% | -52.28% | 312.27% | 1,129.23% | -93.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 223.67% | -209.89% | 112.43% | 43.49% | 7.89% |